Lexenpharm

Lexenpharm is a specialty pharmaceutical company headquartered in Suzhou, China, with a primary focus on the development, manufacturing, and commercialization of high-quality central nervous system (CNS) and cardiovascular medications. The company is recognized for its expertise in high-barrier generics and complex formulations, maintaining state-of-the-art R&D centers in Beijing and GMP-certified manufacturing facilities in Suzhou that comply with US FDA and EU standards. Lexenpharm's portfolio includes widely used treatments for Alzheimer's disease, schizophrenia, and hypertension, many of which have successfully passed China's generic drug consistency evaluation. In addition to its proprietary product line, the company operates as a CDMO, providing formulation development and manufacturing services to global pharmaceutical partners. Lexenpharm aims to bridge the gap between innovative drug delivery and affordable healthcare solutions.